X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
eicosapentaenoic acid (2962) 2962
animals (2560) 2560
humans (2526) 2526
eicosapentaenoic acid - pharmacology (1890) 1890
male (1828) 1828
docosahexaenoic acid (1507) 1507
docosahexaenoic acids - pharmacology (1130) 1130
female (1119) 1119
biochemistry & molecular biology (1030) 1030
rats (988) 988
omega-3 fatty acids (952) 952
polyunsaturated fatty-acids (935) 935
fatty acids (906) 906
fatty acids, omega-3 - pharmacology (869) 869
nutrition & dietetics (804) 804
mice (713) 713
lipids (710) 710
pharmacology & pharmacy (683) 683
unsaturated fatty acids (683) 683
fish-oil (648) 648
adult (620) 620
inflammation (604) 604
dietary supplements (592) 592
fish oils - pharmacology (573) 573
middle aged (546) 546
diet (543) 543
fish oil (463) 463
fatty acids, unsaturated - pharmacology (460) 460
cells, cultured (430) 430
arachidonic acid (422) 422
metabolism (417) 417
fish oils (409) 409
cell biology (397) 397
eicosapentaenoic acid - metabolism (385) 385
eicosapentaenoic acid - administration & dosage (384) 384
polyunsaturated fatty acids (382) 382
supplementation (378) 378
fatty-acids (341) 341
aged (336) 336
eicosapentaenoic acid - analogs & derivatives (336) 336
endocrinology & metabolism (327) 327
dose-response relationship, drug (321) 321
physiological aspects (318) 318
health aspects (317) 317
omega-3-fatty-acids (317) 317
nutrition (316) 316
oxidative stress (315) 315
arachidonic-acid (313) 313
research (310) 310
eicosapentaenoic acid - therapeutic use (301) 301
fatty acids, omega-3 - administration & dosage (297) 297
dietary fats - pharmacology (294) 294
docosahexaenoic acids - administration & dosage (283) 283
rats, wistar (282) 282
triglycerides - blood (279) 279
analysis (277) 277
fatty acids - metabolism (273) 273
apoptosis (267) 267
expression (266) 266
double-blind method (261) 261
fatty acids, omega-3 - therapeutic use (260) 260
alpha-linolenic acid (254) 254
docosahexaenoic acids - metabolism (254) 254
epa (252) 252
lipids - blood (250) 250
cholesterol (248) 248
cardiovascular-disease (243) 243
liver - metabolism (240) 240
life sciences (237) 237
dietary fats, unsaturated - pharmacology (228) 228
oncology (228) 228
gene expression (227) 227
rats, sprague-dawley (226) 226
eicosapentaenoic acid - blood (225) 225
fish oils - administration & dosage (225) 225
double-blind (222) 222
dha (215) 215
n-3 fatty-acids (215) 215
fatty acids, omega-3 - metabolism (214) 214
time factors (214) 214
atherosclerosis (212) 212
arachidonic acid - pharmacology (208) 208
disease models, animal (205) 205
cancer (204) 204
mice, inbred c57bl (204) 204
gene-expression (201) 201
prevention (199) 199
cell line (198) 198
fatty acids, unsaturated - metabolism (196) 196
phospholipids - metabolism (196) 196
rodents (196) 196
n-3 (195) 195
cells (192) 192
gamma-linolenic acid (189) 189
risk factors (187) 187
physiology (185) 185
docosahexaenoic acids - therapeutic use (183) 183
triglycerides (183) 183
disease (182) 182
apoptosis - drug effects (181) 181
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4805) 4805
Japanese (125) 125
Chinese (18) 18
Russian (11) 11
German (9) 9
Italian (3) 3
French (2) 2
Spanish (2) 2
Ukrainian (2) 2
Dutch (1) 1
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 12, p. e114766
In the present study, we noted that bleomycin induced growth inhibitory action was augmented by all the polyunsaturated fatty acids (PUFAs... 
CARCINOMA-CELLS | CANCER-CELLS | NUDE-MICE | INDUCED DIABETES-MELLITUS | LIPID-PEROXIDATION | MULTIDISCIPLINARY SCIENCES | TUMOR-CELLS | GAMMA-LINOLENIC ACID | ARACHIDONIC-ACID | EICOSAPENTAENOIC ACID | PROSTAGLANDIN E-2 | Prostaglandins - pharmacology | Humans | Leukotrienes - pharmacology | Fatty Acids, Unsaturated - pharmacology | Lipoxins - pharmacology | Antioxidants - pharmacology | Fatty Acids, Unsaturated - metabolism | Cyclooxygenase Inhibitors - pharmacology | CD59 Antigens - pharmacology | Docosahexaenoic Acids - pharmacology | Time Factors | Arachidonic Acid - pharmacology | Lipid Peroxidation - drug effects | Cell Line, Tumor | Cell Extracts | Cell Proliferation - drug effects | Cell Death - drug effects | Nitric Oxide - metabolism | Lipoxygenase Inhibitors - pharmacology | Neuroblastoma - pathology | Bleomycin - toxicity | Unsaturated fatty acids | Prostaglandins | Bleomycin | Metabolites | Lectins | Neuroblastoma | Omega-3 fatty acids | Polyunsaturated fatty acids | Oxidizing agents | Science | Lipid peroxidation | Prostaglandin E2 | Cytotoxicity | Lipids | Superoxide dismutase | Metastasis | Kinases | Docosahexaenoic acid | Neuroblastoma cells | Antioxidants | Cell growth | Oxidants | Rodents | Cell cycle | Peroxides | Peroxidase | Inhibition | Pretreatment | Drug dosages | Glutathione | Glutathione peroxidase | Engineering schools | Lipoxin A4 | Nordihydroguaiaretic acid | Breast cancer | Fatty acids | Studies | Leukotrienes | Indomethacin | Superoxide
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 09/2008, Volume 106, Issue 5, pp. 2015 - 2029
Epidermal fatty acid‐binding protein (E‐FABP), a member of the family of FABPs, exhibits a robust expression in neurons during axonal growth in development and in nerve regeneration following nerve injury... 
fatty acid binding | C22:6n‐3 docosahexaenoic acid | C20:5n‐3 eicosapentaenoic acid | n‐3/n‐6 polyunsaturated fatty acids | neuronal differentiation | epidermal fatty acid‐binding protein | C22:6n-3 docosahexaenoic acid | Neuronal differentiation | Fatty acid binding | Epidermal fatty acid-binding protein | C20:5n-3 eicosapentaenoic acid | n-3/n-6 polyunsaturated fatty acids | epidermal fatty acid-binding protein | PROLIFERATOR-ACTIVATED RECEPTORS | BIOCHEMISTRY & MOLECULAR BIOLOGY | LIPID-BINDING PROTEIN | ARACHIDONIC-ACID | NEUROSCIENCES | C20 : 5n-3 eicosapentaenoic acid | NERVE GROWTH-FACTOR | LIGAND SPECIFICITY | MESSENGER-RNA | DOCOSAHEXAENOIC ACID | MEMBRANE-FLUIDITY | C22 : 6n-3 docosahexaenoic acid | RAT-BRAIN | DHA METABOLISM | Oligodeoxyribonucleotides, Antisense - pharmacology | Recombinant Fusion Proteins - pharmacology | Fatty Acid-Binding Proteins - metabolism | PC12 Cells | Fatty Acids, Omega-6 - pharmacology | Eicosapentaenoic Acid - pharmacology | Fatty Acids, Omega-3 - pharmacology | Neurites - ultrastructure | Protein Binding - drug effects | Eye Proteins - genetics | Cell Differentiation - physiology | Neurites - drug effects | MAP Kinase Kinase 1 - antagonists & inhibitors | Fatty Acids, Omega-3 - metabolism | Nerve Growth Factor - metabolism | Eicosapentaenoic Acid - metabolism | Nerve Growth Factor - pharmacology | Rats | MAP Kinase Kinase 1 - metabolism | Neurites - metabolism | Fatty Acid-Binding Proteins - genetics | Fatty Acids, Omega-6 - metabolism | Nerve Tissue Proteins - genetics | Cell Compartmentation - physiology | Nerve Tissue Proteins - metabolism | Docosahexaenoic Acids - pharmacology | Animals | Eye Proteins - metabolism | Cell Differentiation - drug effects | Lipid Metabolism - drug effects | Lipid Metabolism - physiology | Docosahexaenoic Acids - metabolism | Protein Binding - physiology | Unsaturated fatty acids | Nerve growth factor | Omega-3 fatty acids | Neurology | Biochemistry | Cellular biology | Kinases | Fatty acids | n-6 polyunsaturated fatty acids | n-3
Journal Article
PloS one, ISSN 1932-6203, 2013, Volume 8, Issue 2, p. e56233
We questioned if acute administration of n-3 fatty acids (FA) carried in n-3 rich triglyceride (TG... 
STROKE | LIPID EMULSIONS | BLOOD CLEARANCE | BRAIN-INJURY | NEUROINFLAMMATION | DOCOSAHEXAENOIC ACID | OMEGA-3-FATTY-ACIDS | MULTIDISCIPLINARY SCIENCES | PARTICLE-SIZE | MODEL | EICOSAPENTAENOIC ACID | Neuroprotective Agents - therapeutic use | Emulsions | Brain Infarction - pathology | Eicosapentaenoic Acid - administration & dosage | Hypoxia-Ischemia, Brain - pathology | Brain - blood supply | Fatty Acids, Omega-6 - administration & dosage | Fatty Acids, Omega-6 - pharmacology | Neuroprotective Agents - pharmacology | Eicosapentaenoic Acid - pharmacology | Time Factors | Fatty Acids, Omega-3 - pharmacology | Triglycerides - therapeutic use | Bleeding Time | Triglycerides - pharmacology | Brain Infarction - drug therapy | Fatty Acids, Omega-3 - administration & dosage | Animals, Newborn | Docosahexaenoic Acids - therapeutic use | Cerebrovascular Circulation - drug effects | Brain - physiopathology | Mice, Inbred C57BL | Hypoxia-Ischemia, Brain - drug therapy | Injections, Intraperitoneal | Brain Infarction - physiopathology | Docosahexaenoic Acids - administration & dosage | Brain - drug effects | Docosahexaenoic Acids - pharmacology | Animals | Triglycerides - blood | Brain - pathology | Fatty Acids, Omega-3 - therapeutic use | Eicosapentaenoic Acid - therapeutic use | Mice | Blood Glucose - metabolism | Fatty Acids, Omega-6 - therapeutic use | Hypoxia-Ischemia, Brain - physiopathology | Infants (Newborn) | Stroke (Disease) | Unsaturated fatty acids | Brain | Triglycerides | Health aspects | Omega-3 fatty acids | Injuries | Neonates | Pediatrics | Oxidative stress | Neuroprotection | Traumatic brain injury | Lipids | Cardiovascular disease | Docosahexaenoic acid | Head injuries | Ischemia | Cerebral blood flow | Rodents | Carotid artery | Cerebral infarction | Stroke | Nutrition | Fish oils | Injection | Metabolism | Gene expression | Fatty acids | Blood flow | Surgeons | Hypoxia | Infarction | Spinal cord injuries | Laboratory animals | Eicosapentaenoic acid | Brain injury | Apoptosis
Journal Article
Environmental science and pollution research international, ISSN 1614-7499, 2019, Volume 26, Issue 22, pp. 22197 - 22208
... days, in order to evaluate the fatty acid (FA) composition and redox state in the digestive gland of Mactra corallina... 
Oxidative stress | Environmental Health | Ecotoxicology | Exposure | Fatty acids | Environment, general | Acrylamide | Antioxidant status | Mactra corallina | Environment | Digestive gland | Waste Water Technology / Water Pollution Control / Water Management / Aquatic Pollution | Environmental Chemistry | Atmospheric Protection/Air Quality Control/Air Pollution | MUSSELS | MARINE ORGANISMS | METALLOTHIONEIN | SPECTROPHOTOMETRIC METHOD | MODEL | ASCORBIC-ACID | BIOMARKERS | ENVIRONMENTAL SCIENCES | ADDUCT FORMATION | GLUTATHIONE | LIVER | Digestion - drug effects | Eicosapentaenoic Acid - chemistry | Antioxidants - chemistry | Oxidation-Reduction | Docosahexaenoic Acids - chemistry | Glutathione - metabolism | Eicosapentaenoic Acid - analogs & derivatives | Acrylamide - pharmacology | Linoleic Acid - chemistry | Antioxidants - pharmacology | Catalase - metabolism | Animals | Fatty Acids, Omega-3 - pharmacology | Arachidonic Acid - chemistry | Bivalvia - metabolism | Linoleic Acid - pharmacology | Oxidative Stress - drug effects | Fatty Acids - metabolism | Bivalvia - chemistry | Superoxide Dismutase - metabolism | Antioxidants | Unsaturated fatty acids | Hydrogen peroxide | Aquaculture industry | Amides | Mariculture | Peroxidase | Superoxide | Essential fatty acids | Metallothionein | Organic acids | Ascorbic acid | Toxicity | Food contamination | Cytotoxicity | Digestive glands | Superoxide dismutase | Arachidonic acid | Acetylcholinesterase | Docosahexaenoic acid | Fatty acid composition | Catalase | Redox properties | Glutathione | Carbonyls | Glutathione peroxidase | Carbohydrates | Composition | Industrial applications | Contamination | Malondialdehyde | Linoleic acid | Organic chemistry | Eicosapentaenoic acid
Journal Article
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2010, Volume 31, Issue 4, pp. 678 - 687
Abstract Polyunsaturated fatty acids (PUFA) of the omega-3 series and omega-6 series modulate neurite outgrowth in immature neurones... 
Neurology | Internal Medicine | Dorsal root ganglia | Rat | Aged | Docosahexaenoic acid | Arachidonic acid | Eicosapentaenoic acid | Sensory neurones | Omega-3 fatty acids | Neurite outgrowth | ARACHIDONIC-ACID | NEUROSCIENCES | ADULT | PHOSPHOLIPASE-A2 | NERVE GROWTH-FACTOR | GERIATRICS & GERONTOLOGY | CONE LIPIDS | NOCICEPTIVE NEURONS | RETINOID-X-RECEPTOR | PC12 CELLS | BRAIN | Rats, Wistar | Aging - drug effects | Male | Ganglia, Spinal - cytology | Nerve Growth Factors - metabolism | Nerve Growth Factors - pharmacology | Eicosapentaenoic Acid - pharmacology | Fatty Acids, Omega-3 - pharmacology | Neurites - ultrastructure | Up-Regulation - physiology | Female | Neurogenesis - drug effects | Sensory Receptor Cells - metabolism | Neurites - drug effects | Tretinoin - pharmacology | Animals, Newborn | Docosahexaenoic Acids - therapeutic use | Fatty Acids, Omega-3 - metabolism | Cells, Cultured | Eicosapentaenoic Acid - metabolism | Nerve Growth Factor - pharmacology | Rats | Neurites - metabolism | Nerve Growth Factors - therapeutic use | Up-Regulation - drug effects | Docosahexaenoic Acids - pharmacology | Animals | Sensory Receptor Cells - cytology | Sensory Receptor Cells - drug effects | Neurogenesis - physiology | Fatty Acids, Omega-3 - therapeutic use | Eicosapentaenoic Acid - therapeutic use | Ganglia, Spinal - growth & development | Ganglia, Spinal - drug effects | Neurofilament Proteins - metabolism | Aging - metabolism | Docosahexaenoic Acids - metabolism | Unsaturated fatty acids | Nerve growth factor
Journal Article
Journal Article